These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9848803)

  • 1. Interpersonal concerns and psychological difficulties of psoriasis patients: effects of disease severity and fear of negative evaluation.
    Leary MR; Rapp SR; Herbst KC; Exum ML; Feldman SR
    Health Psychol; 1998 Nov; 17(6):530-6. PubMed ID: 9848803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social anxiety and disfigurement: the moderating effects of fear of negative evaluation and past experience.
    Kent G; Keohane S
    Br J Clin Psychol; 2001 Mar; 40(1):23-34. PubMed ID: 11317946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress.
    Fortune DG; Main CJ; O'Sullivan TM; Griffiths CE
    Br J Dermatol; 1997 Nov; 137(5):755-60. PubMed ID: 9415236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fear of evaluation unpacked: day-to-day correlates of fear of negative and positive evaluation.
    Reichenberger J; Smyth JM; Blechert J
    Anxiety Stress Coping; 2018 Mar; 31(2):159-174. PubMed ID: 29119832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia.
    Fortune DG; Richards HL; Griffiths CE; Main CJ
    Br J Clin Psychol; 2002 Jun; 41(Pt 2):157-74. PubMed ID: 12034003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis.
    Root S; Kent G; al-Abadie MS
    Dermatology; 1994; 189(3):234-7. PubMed ID: 7949473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity levels in psoriasis: a separate 'very severe' category not required.
    Kulkarni AS; Horn E; Balkrishnan R; Feldman S
    J Dermatolog Treat; 2009; 20(1):48-51. PubMed ID: 18651301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social coping strategies associated with quality of life decrements among psoriasis patients.
    Rapp SR; Cottrell CA; Leary MR
    Br J Dermatol; 2001 Oct; 145(4):610-6. PubMed ID: 11703288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis.
    Sampogna F; Chren MM; Melchi CF; Pasquini P; Tabolli S; Abeni D;
    Br J Dermatol; 2006 Feb; 154(2):325-31. PubMed ID: 16433804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality-of-life issues in psoriasis.
    Mukhtar R; Choi J; Koo JY
    Dermatol Clin; 2004 Oct; 22(4):389-95, viii. PubMed ID: 15450335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress.
    Gupta MA; Gupta AK
    Acta Derm Venereol; 1995 May; 75(3):240-3. PubMed ID: 7653188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical and psychologic measures are necessary to assess overall psoriasis severity.
    Kirby B; Richards HL; Woo P; Hindle E; Main CJ; Griffiths CE
    J Am Acad Dermatol; 2001 Jul; 45(1):72-6. PubMed ID: 11423838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients.
    Vardy D; Besser A; Amir M; Gesthalter B; Biton A; Buskila D
    Br J Dermatol; 2002 Oct; 147(4):736-42. PubMed ID: 12366421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of psoriasis on psychosocial life domains. A review.
    Wahl A
    Scand J Caring Sci; 1997; 11(4):243-9. PubMed ID: 9505733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of psoriasis is not determined by disease severity only.
    Heydendael VM; de Borgie CA; Spuls PI; Bossuyt PM; Bos JD; de Rie MA
    J Investig Dermatol Symp Proc; 2004 Mar; 9(2):131-5. PubMed ID: 15083779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.
    Fernandez-Peñas P; Jones-Caballero M; Espallardo O; García-Díez A
    Br J Dermatol; 2012 Apr; 166(4):884-7. PubMed ID: 22229951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being.
    Fortune DG; Richards HL; Kirby B; McElhone K; Main CJ; Griffiths CE
    Br J Dermatol; 2004 Dec; 151(6):1219-26. PubMed ID: 15606518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bivalent fear of evaluation model of social anxiety: further integrating findings on fears of positive and negative evaluation.
    Weeks JW; Howell AN
    Cogn Behav Ther; 2012; 41(2):83-95. PubMed ID: 22489647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and gender differences in the impact of psoriasis on quality of life.
    Gupta MA; Gupta AK
    Int J Dermatol; 1995 Oct; 34(10):700-3. PubMed ID: 8537157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis has a major secondary impact on the lives of family members and partners.
    Eghlileb AM; Davies EE; Finlay AY
    Br J Dermatol; 2007 Jun; 156(6):1245-50. PubMed ID: 17459044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.